Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 3
2006 6
2007 6
2008 5
2009 8
2010 13
2011 11
2012 15
2013 14
2014 11
2015 9
2016 11
2017 11
2018 9
2019 6
2020 3
2021 3
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwiński E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster JY, Roux C, Malouf J, Bradley MN, Daizadeh NS, Wang A, Dakin P, Pannacciulli N, Dempster DW, Papapoulos S. Bone HG, et al. Among authors: fahrleitner pammer a. Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523. doi: 10.1016/S2213-8587(17)30138-9. Epub 2017 May 22. Lancet Diabetes Endocrinol. 2017. PMID: 28546097 Clinical Trial.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P. Kendler DL, et al. Among authors: fahrleitner pammer a. Lancet. 2018 Jan 20;391(10117):230-240. doi: 10.1016/S0140-6736(17)32137-2. Epub 2017 Nov 9. Lancet. 2018. PMID: 29129436 Clinical Trial.
FGF23 in Acute and Chronic Illness.
Schnedl C, Fahrleitner-Pammer A, Pietschmann P, Amrein K. Schnedl C, et al. Among authors: fahrleitner pammer a. Dis Markers. 2015;2015:358086. doi: 10.1155/2015/358086. Epub 2015 Sep 28. Dis Markers. 2015. PMID: 26491212 Free PMC article. Review.
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Langdahl B, Hofbauer LC, Ferrari S, Wang Z, Fahrleitner-Pammer A, Gielen E, Lakatos P, Czerwinski E, Gimeno EJ, Timoshanko J, Oates M, Libanati C. Langdahl B, et al. Among authors: fahrleitner pammer a. Osteoporos Int. 2022 Dec;33(12):2527-2536. doi: 10.1007/s00198-022-06544-2. Epub 2022 Sep 29. Osteoporos Int. 2022. PMID: 36173415 Free PMC article. Clinical Trial.
Current controversies in clinical management of postmenopausal osteoporosis.
Kerschan-Schindl K, Mikosch P, Obermayer-Pietsch B, Gasser RW, Dimai HP, Fahrleitner-Pammer A, Dobnig H, Roschger P, Preisinger E, Klaushofer K, Resch H, Pietschmann P. Kerschan-Schindl K, et al. Among authors: fahrleitner pammer a. Exp Clin Endocrinol Diabetes. 2014 Sep;122(8):437-44. doi: 10.1055/s-0034-1374610. Epub 2014 May 16. Exp Clin Endocrinol Diabetes. 2014. PMID: 24838156 Review.
The Bone-Cardiovascular Axis: Mechanisms and Clinical Relevance.
Verheyen N, Grübler MR, Catena C, Fahrleitner-Pammer A, van Ballegooijen AJ. Verheyen N, et al. Among authors: fahrleitner pammer a. Int J Endocrinol. 2018 Feb 21;2018:9689106. doi: 10.1155/2018/9689106. eCollection 2018. Int J Endocrinol. 2018. PMID: 29681938 Free PMC article. No abstract available.
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Verheyen N, Pilz S, Eller K, Kienreich K, Fahrleitner-Pammer A, Pieske B, Ritz E, Tomaschitz A. Verheyen N, et al. Among authors: fahrleitner pammer a. Expert Opin Pharmacother. 2013 Apr;14(6):793-806. doi: 10.1517/14656566.2013.777041. Epub 2013 Mar 4. Expert Opin Pharmacother. 2013. PMID: 23452174 Review.
Update on denosumab in postmenopausal osteoporosis--recent clinical data.
Muschitz C, Fahrleitner-Pammer A, Huber J, Preisinger E, Kudlacek S, Resch H. Muschitz C, et al. Among authors: fahrleitner pammer a. Wien Med Wochenschr. 2012 Sep;162(17-18):374-9. doi: 10.1007/s10354-012-0116-x. Epub 2012 Jun 12. Wien Med Wochenschr. 2012. PMID: 22688622 Review.
129 results